Component
Short-term demand for transmitter GABA
Short-term demand for transmitter GABA. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
Where it participates (unsigned role)
At least 50% of glutamate decarboxylase is present in brain as apoenzyme, that is enzyme without bound cofactor, which serves as a reservoir of inactive enzyme that can be drawn on when additional GABA synthesis is needed, a substantial majority of the apoenzyme in brain is accounted for by GAD65 although GAD67 also contributes, the interaction of the enzyme with pyridoxal 5-phosphate is a major factor in the short-term regulation of its activity, and the apparent localization of GAD65 in nerve terminals together with the large reserve of apo-GAD65 suggest that GAD65 is specialized to respond to short-term changes in demand for transmitter GABA.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/gaba-research/8419527.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0de2df4de7da887745f27b7c4593a75590b6de3649a2b5b35a1d36980a86b755", "start_char": 0, "end_char": 1425, "text_sha256": "0de2df4de7da887745f27b7c4593a75590b6de3649a2b5b35a1d36980a86b755"}
- experimental_model
- Review of the compartments and short-term regulation of brain GABA synthesis
- exposure
- Glutamate decarboxylase measured as apoenzyme and holoenzyme across brain regions
- limitations
- A review of the enzymology. The apoenzyme fraction is given for total glutamate decarboxylase, with GAD65 accounting for a substantial majority of it rather than being separately quantified.
- nutrient_topic
- GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. · Gamma-aminobutyric acid
- organism
- Rat and human
- plain_language
- Half the enzyme is sitting idle without its cofactor, held in reserve for when more transmitter is suddenly needed.
- primary_references
- [gb-p8419527] Regulation of gamma-aminobutyric acid synthesis in the brain. (1993). https://pubmed.ncbi.nlm.nih.gov/8419527/ DOI: 10.1111/j.1471-4159.1993.tb03165.x
- tissue_or_cell_type
- Brain
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Review of the compartments and short-term regulation of brain GABA synthesis · source_derived_draft · unverified_draft
### gb-half-the-enzyme-waits At least 50% of glutamate decarboxylase is present in brain as apoenzyme, that is enzyme without bound cofactor, which serves as a reservoir of inactive enzyme that can be drawn on when additional GABA synthesis is needed, a substantial majority of the apoenzyme in brain is accounted for by GAD65 although GAD67 also contributes, the interaction of the enzyme with pyridoxal 5-phosphate is a major factor in the short-term regulation of its activity, and the apparent localization of GAD65 in nerve terminals together with the large reserve of apo-GAD65 suggest that GAD65 is specialized to respond to short-term changes in demand for transmitter GABA. Condition category: normal nutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in. plain_language: Half the enzyme is sitting idle without its cofactor, held in reserve for when more transmitter is suddenly needed. organism: Rat and human tissue_or_cell_type: Brain experimental_model: Review of the compartments and short-term regulation of brain GABA synthesis limitations: A review of the enzymology. The apoenzyme fraction is given for total glutamate decarboxylase, with GAD65 accounting for a substantial majority of it rather than being separately quantified. exposure: Glutamate decarboxylase measured as apoenzyme and holoenzyme across brain regions evidence_span: {"source_cache": "artifacts/gaba-research/8419527.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0de2df4de7da887745f27b7c4593a75590b6de3649a2b5b35a1d36980a86b755", "start_char": 0, "end_char": 1425, "text_sha256": "0de2df4de7da887745f27b7c4593a75590b6de3649a2b5b35a1d36980a86b755"} [gb-p8419527] Regulation of gamma-aminobutyric acid synthesis in the brain. (1993). https://pubmed.ncbi.nlm.nih.gov/8419527/ DOI: 10.1111/j.1471-4159.1993.tb03165.x
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.